L01XK04 talazoparib
ATC group of level 5 – chemical substance · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 5 medicines in this group.
- 5 prescription only (POM)
Active substance: Talazoparib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01X Other antineoplastic agents 225 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XK04 talazoparib 5 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Talzenna 0.1 mg hard capsules SPC | Prescription only (POM) |
| Talzenna 0.25 mg hard capsules SPC | Prescription only (POM) |
| Talzenna 0.35 mg hard capsules SPC | Prescription only (POM) |
| Talzenna 0.5 mg hard capsules SPC | Prescription only (POM) |
| Talzenna 1 mg hard capsules SPC | Prescription only (POM) |
Other groups of the same level
- L01XK01 olaparib 3 medicines
- L01XK02 niraparib 2 medicines
- L01XK03 rucaparib 3 medicines
Other names of the ATC group
- German: L01XK04 Talazoparib
- German: L01XK04 Talazoparib
- Italian: L01XK04 TALAZOPARIB
- Turkish: L01XK04 talazoparib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01XK04
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.